AZBio Board of Directors

David B. Patience

Chief Financial Officer

Accelerate Diagnostics, Inc.



David Patience has served as the Company’s Chief Financial Officer from April 2023 to the present. Prior to this he served as Senior Director – Business Development and Strategic Finance from February 2021 to April 2023. From September 2017 to January 2021, Mr. Patience served as the Company’s Head of Finance, Planning and Analysis and Corporate Development. Throughout his time with the Company, Mr. Patience has led strategic product portfolio planning, which includes in-depth market analysis of organic and in-organic portfolio opportunities and technical and commercial feasibility to deliver financial analysis of partnerships, mergers and acquisitions and organic programs. Most recently, Mr. Patience has led the operationalization of the Company’s global sales and marketing agreement with Becton, Dickinson and Company.

Prior to joining the Company, Mr. Patience held positions with Morgan Stanley’s Investment Banking Division, Continental Advisors equity group, and various financial research roles at Nuveen Investments. Mr. Patience holds a Bachelor of Science in Business Administration from the University of Colorado Leeds School of Business and an M.B.A. from the University of Chicago Booth School of Business.